×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Product Crisis Management: Crisis, What Crisis?
Session Chair(s)
Mariette Boerstoel-Streefland, MD, MBA, MS
Senior Vice President, Worldwide Safety Officer
Bristol-Myers Squibb Company, United States
Pharmacovigilance: Planning for a Pandemic
Learning Objective : Explain what constitutes a product crisis; Describe the best practices in the pharmaceutical industry to manage a product crisis; Discuss how to arrive at an effective crisis communication plan; Determine who are the players in case of a crisis; Describe what is being done in other industries including what can be learned by the pharmaceutical industry.
Speaker(s)
Planning for the Unexpected: Product Crisis Management
Cesare Pinto
Bayer HealthCare Pharmaceuticals, United States
Director, Medical Information Services
Dousing the Flames: Audience-Directed Interventions for Crisis Communications
Gil Bashe
FINN Partners, United States
Managing Partner, Chair, Global Health
Pharmacovigilance: Planning for a Pandemic
Libbie Parker McKenzie, MD
Quintiles Transnational Corp. , United States
VP Lifecycle Safety Mgmt; Global Head, Safety Surveillance and Benefit-Risk Mgmt
Have an account?